StreetAlpha.app
Home › Stocks › MRK

Merck & Co., Inc. (MRK)

Healthcare
$133.72
▲ +0.69%
LAST CLOSE · NOV 20

Merck is a health care company that makes prescription medicines, vaccines and animal health products for hospitals, doctors, farmers and pet owners. It last closed at $133.72 on Nov 20, up 0.69% on the day. The next earnings report for MRK is expected around Tue, Feb 2, 2027. For the quarter ended Sep 2026, MRK reported EPS of $2.04 on revenue of $18.09B, with revenue up 4.7% from a year ago. Over its last 8 reports the stock moved an average of 2.5% the session after earnings. Over the last 12 months MRK insiders bought $0 of stock on the open market and sold $79.3M, according to SEC Form 4 filings.

AI Auto Pilots
Is MRK in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MRK.

Key Stats

Last 12 months
Results
Revenue
$67.4B
+4.9% vs a year ago
Net income
$2.5B
−87.1% vs a year ago
EPS (diluted)
$0.99
−86.9% vs a year ago
Free cash flow
$14.7B
21.9% margin
Valuation
Market cap
$330B
2.47B shares
P/E
135.1
Price over 12 month EPS
Price to sales
4.9
Market cap over revenue
Dividend yield
2.54%
$3.40 a share over 12 months
Balance sheet
Cash & equivalents
$9.6B
At Sep 30
Debt
$53.8B
At Sep 30
Shareholder equity
$44.9B
Buybacks
$3.5B
Last 12 months
CEORob Davis
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $48.7B$48.7BFY2021FY2022: $59.3B$59.3BFY2022FY2023: $60.1B$60.1BFY2023FY2024: $64.2B$64.2BFY2024FY2025: $65.0B$65.0BFY2025

From MRK's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 2
Estimated date · Time not announced
Reported EPS
$2.04
Quarter ended Sep 2026
Year ago EPS
$2.32
−12.1% on a GAAP basis
Revenue
$18.09B
+4.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $1.48Dec '24Mar 2025: $2.01Mar '25Jun 2025: $1.76Jun '25Sep 2025: $2.32Sep '25Dec 2025: $1.20Dec '25Mar 2026: -$1.72Mar '26Jun 2026: -$0.54Jun '26Sep 2026: $2.04Sep '26Latest $2.04
Revenue by quarter
Dec 2024: $15.62BDec '24Mar 2025: $15.53BMar '25Jun 2025: $15.81BJun '25Sep 2025: $17.28BSep '25Dec 2025: $16.40BDec '25Mar 2026: $16.29BMar '26Jun 2026: $16.61BJun '26Sep 2026: $18.09BSep '26Latest $18.09B
How MRK moved after its last 8 reports
Average move the session after a report ±2.5%
Oct 29, 2026Time not announced+3.8%
Aug 4, 2026Time not announced+0.2%
Apr 30, 2026Time not announced−1.6%
Feb 3, 2026Time not announced+2.2%
Oct 30, 2025Time not announced−0.3%
Jul 29, 2025Time not announced−1.7%
Apr 24, 2025Time not announced+1.4%
Feb 4, 2025Time not announced−9.1%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on MRKStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on MRK
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on MRK

Technical Analysis

MRK · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 8% below its 20 day and 9% below its 50 day average. It is 3% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 34), near oversold. The nearest support is the Pivot S1 at $132.16, and the nearest resistance the Pivot at $134.67.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 3.4%/day
Key levels
$156.9252 week high+17.3%
$145.2850 day average+8.6%
$144.3620 day average+8.0%
$140.66100 day average+5.2%
$136.22Pivot R1+1.9%
$135.05Swing high (Jul 28)+1.0%
$134.67Pivot+0.7%
$133.72Last close
$132.16Pivot S1−1.2%
$129.22200 day average−3.4%
$126.22Swing low (Aug 4)−5.6%
$93.9052 week low−29.8%
Indicators
RSI (14)33.77Weak, oversold below 30Neutral
MACD-2.13Below its signal lineBearish
Stochastic7.8Near the bottom of its rangeOversold
ADX (14)18.1No clear trend
Williams %R-89.3Oversold below −80, overbought above −20Oversold
CCI (20)-184.0Oversold below −100, overbought above 100Oversold
Rate of change−8.9%Change over 10 sessionsBearish
ATR (14)$4.51Typical daily range, 3.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for MRK

What happened before

See how MRK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow MRK usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How MRK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for MRKHow many large options trades hit MRK, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

MRK Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●1,780 buying vs 1,664 selling
  • ▼Held by funds -2.2 pts
  • ▲Funds holding +121
  • ▲Superinvestors: 5 added, 0 cut
  • ▲Put/call 1.36 to 1.24
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding3,9813,860+3.1%
In funds' top 1010979+38.0%
Held by funds78.3%80.5%−2.2 pts
New / increased270 / 1,510160 / 1,572+2.8%
Reduced / sold out1,551 / 1131,471 / 118+4.7%
Put/call ratio1.241.36−8.9%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MRK institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

MRK Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$79.3M20 sales · 10 insiders
2026-02 sold $40.7M2026-08 sold $30.0M2026-11 sold $8.6MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 12Richard R. DeLucaEVP&Pres, Merck Animal HeallthSale58,185$148.01$8.6M
Aug 13Chirfi GuindoEVP, Access, Policy & CommsSale10,000$135.00$1.4M
Aug 12Jennifer ZacharyEVP, General CounselSale80,315$133.46$10.7M
Aug 12Richard R. DeLucaEVP&Pres, Merck Animal HeallthSale45,320$131.12$5.9M
Aug 6Richard R. DeLucaEVP&Pres, Merck Animal HeallthSale6,050$130.38$789K
Aug 6Chirfi GuindoEVP, Access, Policy & CommsSale15,000$131.00$2.0M
Every insider buy and sale for MRK over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See MRK insider trades →

From SEC Form 4 filings by MRK's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

MRK Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$3.5B
1.1% yield
Left in program
$5.1B
1.5% of value
Shares outstanding, 12 months
−0.7%
Fewer shares
Last quarter
$653.9M
Sep 2026
Avg price paid, last quarter
$136.86
4.8M shares bought
S&P 500 rank by spending
#69 of 358
 
Spent each quarter, last 3 yearsTop bar $1.3B
Dec 2023: $393.3M, average price $103.36Mar 2024: $121.6M, average price $122.71Jun 2024: $251.2M, average price $128.97Sep 2024: $444.3M, average price $117.89Dec 2024: $482.9M, average price $104.15Mar 2025: $1.2B, average price $92.32Jun 2025: $1.3B, average price $79.40Sep 2025: $1.3B, average price $82.19Dec 2025: $1.3B, average price $92.60Mar 2026: $873.8M, average price $114.07Jun 2026: $711.1M, average price $116.55Sep 2026: $653.9M, average price $136.86
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MRK is in one of them and how their past MRK trades turned out.

MRK in the AI portfolios
Loading…

MRK News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MRK in an article yet. Here's the latest on the wider market.

MRK in the news

MRK Congress Trades

All congress trades →
Trades, 12 months
17
Buys
9
53%
Sells
8
47%
People
7
Last filed Nov 5
Who traded MRK · since 2014
Latest 5 filings of 239
$15K – $50KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 2, 2026Filed Nov 5, 2026
$50K – $100KTraded Aug 28, 2026Filed Oct 14, 2026
Maria Elvira SalazarSell (partial)
$1K – $15KTraded Sep 24, 2026Filed Oct 7, 2026
Ro KhannaSell (partial)
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$15K – $50KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CABuy$1K – $15KOct 2, 2026Nov 5, 202634 d
Michael McCaulR · TXSell$50K – $100KAug 28, 2026Oct 14, 202647 d
Maria Elvira SalazarR · FLSell (partial)$1K – $15KSep 24, 2026Oct 7, 202613 d
Ro KhannaD · CASell (partial)$1K – $15KSep 4, 2026Oct 7, 202633 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Merck & Co.

Merck is a health care company based in Rahway, New Jersey. Its Pharmaceutical segment makes prescription medicines and vaccines for human disorders, including cancer treatments and therapies for heart, lung and infectious conditions. It sells these mainly to drug wholesalers, retailers, hospitals, government agencies and managed care providers. Its Animal Health segment makes veterinary medicines, vaccines and monitoring products for livestock and companion animals, sold to veterinarians, distributors, farmers and pet owners.

Headquarters
Rahway, NJ
Founded
1891
Website
msd.no ↗